|
Post by millton on Jan 29, 2016 21:54:53 GMT
|
|
|
Post by millton on Aug 19, 2016 5:04:38 GMT
|
|
|
Post by actcfan on Aug 19, 2016 13:47:33 GMT
Looks like an interesting company. Do you have any sense of the competitive landscape, how does their test compare in accuracy compared to the higher cost DNA tests?
|
|
|
Post by millton on Aug 20, 2016 15:39:04 GMT
Link for company presentation. Page thirteen has a comparison of tests For the record Im not normally a Bio guy, I thought I would throw this one out there because it seemed really interesting. I mean who wouldn't prefer a blood test over the alternatives. Exact sciences has a 2billion +market cap for poking around in peoples poop So a simple blood test seems like a no brainer if it proves out. content.equisolve.net/volitionrx/media/350687a690a255722a20e187cd1839e0.pdf
|
|
|
Post by magnus123 on May 9, 2019 9:18:34 GMT
Anyone invested here? I bought a bigger position last year at $1.78. They had a nice really since then. The company is actually well funded with appr. 21 Million cash on hand and possibly additional 5 Million in cash through warrants, wich are exercisable at $3. A lot of catalysts this year with numerous study results coming. Potential approved product in Vet next year with some revenue possible then. I am acutally very confident in Management. The current pps is maybe a little high to invest, but it is a higly volatile stock with low volume, so this could easily fall under $3 and that yould be a nice buying opportunity. Here their last report, announced yesterday: ir.volitionrx.com/press-releases/detail/666/volitionrx-limited-announces-first-quarter-2019-financial
|
|
|
Post by JHam on May 13, 2019 13:42:36 GMT
Anyone invested here? I bought a bigger position last year at $1.78. They had a nice really since then. The company is actually well funded with appr. 21 Million cash on hand and possibly additional 5 Million in cash through warrants, wich are exercisable at $3. A lot of catalysts this year with numerous study results coming. Potential approved product in Vet next year with some revenue possible then. I am acutally very confident in Management. The current pps is maybe a little high to invest, but it is a higly volatile stock with low volume, so this could easily fall under $3 and that yould be a nice buying opportunity. Here their last report, announced yesterday: ir.volitionrx.com/press-releases/detail/666/volitionrx-limited-announces-first-quarter-2019-financialThanks for letting us know. I will check it out.
|
|
|
Post by magnus123 on Jul 24, 2019 19:02:40 GMT
Very strong move the last days. Up to $4.13 now. Commenced recently a study in China with Fosun regarding lung cancer. Results expected by the end of the year. Many study results yet to come. Exciting time actually here.
|
|
|
Post by JHam on Jul 26, 2019 5:38:50 GMT
Very strong move the last days. Up to $4.13 now. Commenced recently a study in China with Fosun regarding lung cancer. Results expected by the end of the year. Many study results yet to come. Exciting time actually here. Wow, that's an impressive run, congrats! Looks like they just exercised those warrants.
|
|
|
Post by magnus123 on Jul 26, 2019 22:55:48 GMT
Very strong move the last days. Up to $4.13 now. Commenced recently a study in China with Fosun regarding lung cancer. Results expected by the end of the year. Many study results yet to come. Exciting time actually here. Wow, that's an impressive run, congrats! Looks like they just exercised those warrants. Thanks! The exercisement of the warrants is indeed very nice. Brings in even more cash at nice concitions. They should have at the end of Q2 appr. $23.5 Million cash, which is the best financial situation ever in the company. The investor (Cotterford), who exercised the warrants, owns now more than 29% of the company. I believe that this is also a very good sign.
|
|
|
Post by magnus123 on Aug 18, 2019 15:05:38 GMT
Last earnings report: ir.volition.com/press-releases/detail/672/volitionrx-limited-announces-second-quarter-2019-financial$23.3 Million in cash, which is the best financial situation ever. They are very disciplined with cash usage. A lot of study data will come this year and early next year. They're also in progress of CE marking in Europe and Asia for their CRC Triage product (FIT + Volition's Nu.Q). The big deal is the frontline screening product, but the Triage product is a beginning. Their vetenary stragey is also pacing up which a planned commercial start next year.
|
|
|
Post by magnus123 on Sept 21, 2019 10:13:43 GMT
Strong week here with a new 52w high of $4.77. Significant breakthrough in one of their programs (Nu.Q Capture), which could be of tremendous value for them in the future.
|
|
|
Post by magnus123 on Sept 24, 2019 17:21:52 GMT
Crazy rally here without any news. More than 30% up on heavy volume. I'm wondering whats the reason for this rally is.
|
|
|
Post by JHam on Sept 24, 2019 17:26:26 GMT
Crazy rally here without any news. More than 30% up on heavy volume. I'm wondering whats the reason for this rally is. Congrats!
|
|